Using a needle biopsy to study abdominal or pelvic tumors
Part of Cancer clinical trials.
This trial uses a special needle (TRU-Cut biopsy) to take a small tissue sample from a tumor in your abdomen or pelvis. The goal is to better understand the type of cancer and help guide your treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a suspicious growth or spot in your abdomen or pelvis that could be cancer.
- You are 18 years old or older.
- You are not pregnant.
- You are able to carry out daily activities (your cancer center will check this with a simple scale).
- You agree to sign a consent form explaining the procedure.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial checks if an ultrasound-guided tru-cut biopsy (a small needle sample) is safe and accurate in people with suspected advanced ovarian cancer. It may help avoid more invasive surgery to get a diagnosis.
This trial tests whether a special biopsy (called a tru-cut biopsy) can help doctors better understand and manage unusual growths in the uterus that look like fibroids but may not be typical. It is for women who are already planning to have surgery for such a growth.
This study looks at how well an ultrasound-guided needle biopsy (Tru-Cut) can safely collect tissue samples from pelvic masses. It may help doctors confirm diagnoses and guide treatment by improving how biopsies are done in real-world care.
This trial tests whether a needle biopsy through the cervix (transcervical true-cut biopsy) can accurately diagnose uterine masses before surgery. It might help women avoid a more invasive procedure if the biopsy shows a non-cancerous mass.
This trial tests a guidance technique that uses ultrasound images matched to MRI (a real-time “map”) to help track the needle position during treatment for cervical or uterine cancer. It may help make radiation treatments more precise for people who are getting curative-intent radiation with brachytherapy.
This study uses advanced DNA testing on tumor samples to help match cancer treatments more precisely. It may help researchers learn which cancer changes are driving your tumor and how they relate to treatment choices.
Hear when a new Tumor trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.